Andrada, Necel .
HRN: 27-96-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2025
CEFUROXIME 500MG (TAB)
10/20/2025
10/27/2025
ORAL
500 Mg
BID
S/p Nsvd With Rmle; Thinly Msaf
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes